Join Dementia Research News

The US Food and Drink Administration (FDA) has this week approved the first drug since 2003 to treat Alzheimer’s disease. Aducanumab, created by US pharmaceutical company Biogen, is an antibody designed to target amyloid, a protein that builds up in the brains of people with early stages of Alzheimer’s disease. Whereas other existing treatments help […]

Every year we ask our Join Dementia Research volunteers to tell us about their experiences of the service via a questionnaire. This helps us to understand what we are doing well and identify areas for improvement. Engagement Despite the challenges of 2020 it was fantastic to see that many of our volunteers are still engaged […]

As the Neuroscience Team Leader at MAC Clinical Research; an honorary researcher at Lancaster University and a community event organiser, Dr Penny Foulds explains why Join Dementia Research is central to what she does. Personal experience “I have personal experience of dementia in my family” explains Penny, “my grandparents developed Alzheimer’s disease and it was […]

Research volunteer Niall first came across Join Dementia Research on Twitter and was keen to sign up having experienced dementia in his family. Niall lost both his mother and mother-in-law to dementia and having witnessed their gradual fading away, he wants to do whatever he can to contribute towards our understanding of the disease and […]

It is well documented that music and singing are beneficial to those living with dementia. Listening to or singing songs can provide both behavioural and emotional benefits and the power of music can unlock memories and help provide links to a person’s past and promote connection with carers. Researchers at Nottingham University are looking for […]

Lewy body dementia (LBD) is one of the most common forms of dementia. The symptoms of LBD can affect a variety of brain functions including; thinking, attention, sleeping and perception. It is often difficult to diagnose and can appear similar to other medical issues such as delirium. Researchers at the University of Cambridge are looking […]

Dementia can impair the ability of the individual to manage their financial affairs. This means that they will require support from family members in ensuring good financial outcomes and protection. Often those living with dementia enter into a power of attorney agreement that empowers a named person to act on their behalf and assist them […]

More than one million participants have now taken part in COVID-19 research across the UK. We would like to thank all the Join Dementia Research volunteers who have contributed towards this achievement. This milestone has been achieved across England, Northern Ireland, Scotland and Wales by members of the public, NHS doctors and nurses, NIHR research […]

Alzheimer’s disease affects approximately 70% of people diagnosed with dementia, and an estimated 26 million people worldwide. In the very early stages, Alzheimer’s disease may be referred to or diagnosed as Mild Cognitive Impairment (MCI). There are no available treatments to prevent or delay the start of Alzheimer’s disease and currently medications only provide a […]

As we turn six today, we are celebrating not only six years of bringing researchers and volunteers together, but also our collective achievement of helping dementia research to keep going during the pandemic.   See what our volunteers, charity partners and researchers have to say about us!   Since Join Dementia Research began, an incredible […]